Trial Profile
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Panitumumab (Primary)
- Indications Adenocarcinoma; Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms GOX-P
- 09 Mar 2017 Status changed from active, no longer recruiting to completed.
- 24 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 06 Dec 2013 Planned end date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov.